InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (62 oper.)
Historial del iniciado
ConsejeroCompras declaradas
0
Ventas declaradas
62
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Borgeson Blake, Consejero. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 78 filings have been recorded. Split: 0 buy · 62 sells. Total volume traded: €8.2m. Activity tracked since 1 July 2021. The latest transaction was disclosed on 4 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Borgeson Blake
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones78 en total
30.000 títulos@ 3,25 US$Class A Common StockSEC:0001856094-26-000014:0
40.000 títulos@ 3,9625 US$0.0090% mcap1.7% de su flujoClass A Common StockSEC:0001856094-26-000011:0
88.424 títulosClass A Common StockSEC:0001601830-26-000088:0
30.000 títulos@ 3,68 US$0.0051% mcap1.8% de su flujoClass A Common StockSEC:0001856094-26-000008:0
30.000 títulos@ 3,10 US$1.5% de su flujoClass A Common StockSEC:0001856094-26-000003:0
170.000 títulos@ 3,46 US$6.1% de su flujoClass A Common StockSEC:0001601830-26-000045:0
220.000 títulos@ 4,20 US$9.4% de su flujoClass A Common StockSEC:0001601830-26-000007:0
220.000 títulos@ 4,36 US$9.9% de su flujoClass A Common StockSEC:0001856094-26-000002:0
220.000 títulos@ 4,37 US$13.4% de su flujoClass A Common StockSEC:0001856094-25-000006:0
22.016 títulos0Class A Common StockSEC:0001601830-25-000112:0
1734 títulos0Class A Common StockSEC:0001601830-25-000004:0
11.447 títulos@ 7,6402 US$1.6% de su flujoClass A Common StockSEC:0001601830-24-000205:0
11.447 títulos@ 6,7202 US$1.4% de su flujoClass A Common StockSEC:0001601830-24-000186:0
11.447 títulos@ 6,6678 US$1.4% de su flujoClass A Common StockSEC:0001601830-24-000179:0
2026 títulos0Class A Common StockSEC:0001601830-24-000174:0
11.447 títulos@ 6,2156 US$1.3% de su flujoClass A Common StockSEC:0001601830-24-000166:0
11.447 títulos@ 6,8431 US$1.4% de su flujoClass A Common StockSEC:0001601830-24-000160:0
11.447 títulos@ 6,2652 US$1.3% de su flujoClass A Common StockSEC:0001601830-24-000154:0
11.447 títulos@ 7,1226 US$1.4% de su flujoClass A Common StockSEC:0001601830-24-000129:0
11.447 títulos@ 6,8213 US$1.4% de su flujoClass A Common StockSEC:0001601830-24-000119:0
11.447 títulos@ 8,4774 US$1.7% de su flujoClass A Common StockSEC:0001601830-24-000104:0
11.447 títulos@ 7,315 US$1.5% de su flujoClass A Common StockSEC:0001601830-24-000100:0
1441 títulos0Class A Common StockSEC:0001601830-24-000096:0
11.447 títulos@ 9,5052 US$2.0% de su flujoClass A Common StockSEC:0001601830-24-000094:0
11.447 títulos@ 8,4531 US$1.8% de su flujoClass A Common StockSEC:0001601830-24-000082:0
25 de 78 declaraciones
About Borgeson Blake
Borgeson Blake is Administrateur at Recursion Pharmaceuticals, INC. (XNAS). Across 77 filings, and within the 77 sampled filings from 2021-07-06 to 2026-07-09, the activity consists only of sales, for a total of EUR 8148728 and no purchases.
